301
Views
17
CrossRef citations to date
0
Altmetric
Drug Evaluation

Duloxetine: a new selective and dual-acting antidepressant

, &
Pages 421-427 | Published online: 27 Feb 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

M. Kątny & M. Frankowski. (2017) Impurities in Drug Products and Active Pharmaceutical Ingredients. Critical Reviews in Analytical Chemistry 47:3, pages 187-193.
Read now
Stephen E. Nicolson, Jason P. Caplan, Deidre E. Williams & Theodore A. Stern. (2009) Comorbid Pain, Depression, and Anxiety: Multifaceted Pathology Allows for Multifaceted Treatment. Harvard Review of Psychiatry 17:6, pages 407-420.
Read now
Norbert Müller, Rebecca Schennach, Michael Riedel & Hans-Jürgen Möller. (2008) Duloxetine in the treatment of major psychiatric and neuropathic disorders. Expert Review of Neurotherapeutics 8:4, pages 527-536.
Read now

Articles from other publishers (14)

Tintu K. Kuruvilla, S. Muthu, Johanan Christian Prasana, Jacob George & S. Sevvanthi. (2019) Spectroscopic (FT-IR, FT-Raman), quantum mechanical and docking studies on methyl[(3S)-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amine. Journal of Molecular Structure 1175, pages 163-174.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 111 143 .
Michael Namaka, Christine Leong, Amy Grossberndt, Meghann Klowak, Dana Turcotte, Farid Esfahani, Andrew Gomori & Howard Intrater. (2009) A Treatment Algorithm for Neuropathic Pain: An Update. The Consultant Pharmacist 24:12, pages 885-902.
Crossref
Florian Wakenhut, Gill A. Allan, Paul V. Fish, M. Jonathan Fray, Anthony C. Harrison, Rachel McCoy, Stephen C. Phillips, Alan Stobie, Dominique Westbrook, Simon L. Westbrook & Gavin A. Whitlock. (2009) N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: Impact of small structural modifications on P-gp recognition and CNS penetration. Bioorganic & Medicinal Chemistry Letters 19:17, pages 5078-5081.
Crossref
Jens-Uwe Peters, Patrick Schnider, Patrizio Mattei & Manfred Kansy. (2009) Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds. ChemMedChem 4:4, pages 680-686.
Crossref
Anthony L. Vaccarino, Terrence L. Sills, Kenneth R. Evans & Amir H. Kalali. (2009) Multiple Pain Complaints in Patients With Major Depressive Disorder. Psychosomatic Medicine 71:2, pages 159-162.
Crossref
Anthony L. Vaccarino, Terrence L. Sills, Kenneth R. Evans & Amir H. Kalali. (2008) Prevalence and association of somatic symptoms in patients with Major Depressive Disorder. Journal of Affective Disorders 110:3, pages 270-276.
Crossref
Florian Wakenhut, Paul V. Fish, M. Jonathan Fray, Ian Gurrell, James E. Mills, Alan Stobie & Gavin A. Whitlock. (2008) N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters 18:15, pages 4308-4311.
Crossref
Gavin A. Whitlock, Paul V. Fish, M. Jonathan Fray, Alan Stobie & Florian Wakenhut. (2008) Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity. Bioorganic & Medicinal Chemistry Letters 18:9, pages 2896-2899.
Crossref
Gavin A. Whitlock, Julian Blagg & Paul V. Fish. (2008) 1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity. Bioorganic & Medicinal Chemistry Letters 18:2, pages 596-599.
Crossref
José Diego Yllanes Vizcay, Adrián Cano Prous & Gloria Sarria Quiroga. (2008) Mejoría del dolor articular en un cuadro depresivo concomitante tratado con duloxetina. Psiquiatría Biológica 15:1, pages 23-26.
Crossref
Jing Yang, Xiumei Lu, Yujin Bi, Feng Qin & Famei Li. (2007) Chiral Separation of Duloxetine and Its R-Enantiomer by LC. Chromatographia 66:5-6, pages 389-393.
Crossref
Paul V. Fish, M. Jonathan Fray, Alan Stobie, Florian Wakenhut & Gavin A. Whitlock. (2007) N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters 17:7, pages 2022-2025.
Crossref
Shuang Liu & Bruce F. Molino. 2007. Annual Reports in Medicinal Chemistry Volume 42. Annual Reports in Medicinal Chemistry Volume 42 13 26 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.